| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |